For one of the most mature markets in the world, Japan continues to offer huge opportunities for growth. It is the largest pharmaceutical market in the Asia Pacific region and second only to North America worldwide. With government healthcare reforms spurring innovation, Japan equals the promise of emerging countries without the risk.

Quintiles’ integrated teams, backed by our global standards, processes and technology, provide the expertise you need to confidently develop and market therapies in Japan.

Whether you’re looking to enter Japan only or the larger Asia Pacific market, trust Quintiles to help deliver on your globalization objectives.